balsam antireumatic, 3g
luoyang muchun pharmaceutical company ltd -
balsam esential, 5ml
luoyang muchun pharmaceutical company ltd -
balsam antireumatic "tiger balm", 18,4g
luoyang muchun pharmaceutical company ltd -
deflamol 350 ui/400 ui/g unguent
sopharma ad - retinoli palmitas + ergocalciferolum - unguent - 350 ui/400 ui/g
deflamol 350 ui/400 ui/g unguent
sopharma ad - retinoli palmitas + ergocalciferolum - unguent - 350 ui/400 ui/g
liniment balsamic wishnevsky liniment
csp "ucf borsceagov" sap - liniment
theraflu bro unguent
novartis consumer health schweiz ag - o combinatie - unguent
fervex pentru adulti""
upsa sas - franta - combinatii - gran. pt. sol. orala - alte analgezice si antipiretice anilide (inclusiv combinatii)
alunbrig
takeda pharma a/s - brigatinib - carcinom, pulmonar non-celulă mică - agenți antineoplazici - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.
rubraca
pharmaand gmbh - rucaparib camsylate - neoplasme ovariene - agenți antineoplazici - rubraca is indicated as monotherapy for the maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. rubraca este indicat în monoterapie pentru tratamentul de întreținere al pacienților adulți cu platină sensibile recidivat de înaltă calitate epitelial ovarian, al trompelor uterine sau cancer peritoneal primar care sunt în răspuns (completă sau parțială) la chimioterapia pe bază de platină.